Comparative study of anti-inflammatory and ulcerogenic activities of different cyclo-oxygenase inhibitors

被引:10
|
作者
Gambero A. [1 ]
Becker T.L. [1 ]
Zago A.S. [1 ]
De Oliveira A.F. [1 ]
Pedrazzoli Jr. J. [1 ]
机构
[1] Clinical Pharmacology and Gastroenterology Unit, São Francisco University Medical School, 12916-900, Braganca Paulista, SP
关键词
Air pouch; Cyclo-oxygenases; Leukocyte; Non-steroidal anti-inflammatory drugs; Prostaglandin E[!sub]2[!/sub;
D O I
10.1163/156856005774649377
中图分类号
学科分类号
摘要
The aim of the present work was to study the in vivo anti-inflammatory activity of six NSAIDs, ibuprofen, diclofenac, nimesulide, meloxicam, celecoxib and rofecoxib, using the rat air-pouch model of inflammation to characterize the ability of these drugs to induce gastric damage and PGE2 inhibition. Selective compounds were observed to have no ulcerogenic properties at antiinflammatory doses; however, these drugs were weaker inhibitors of several inflammatory aspects such as cell influx and exudate formation. In contrast, the non-selective and preferential compounds present anti-inflammatory properties at lower doses than presented by selective drugs. At antiinflammatory doses, only meloxicam and ibuprofen produced gastric damage and inhibition of PGE 2 synthesis, suggesting that ulcerogenic properties of NSAIDs cannot be predicted by their selectivity index, since meloxicam demonstrates ulcerogenic properties despite its preferential profile. © VSP 2005.
引用
收藏
页码:441 / 454
页数:13
相关论文
共 50 条
  • [31] Is there a Future for Cyclo-Oxygenase Inhibitors in Alzheimer’s Disease?
    Lap Ho
    Weiping Qin
    Breton S. Stetka
    Giulio M. Pasinetti
    CNS Drugs, 2006, 20 : 85 - 98
  • [32] Cyclo-oxygenase (COX) inhibitors for treating preterm labour
    Reinebrant, Hanna E.
    Pileggi-Castro, Cynthia
    Romero, Carla L. T.
    dos Santos, Rafaela A. N.
    Kumar, Sailesh
    Souza, Joao Paulo
    Flenady, Vicki
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (06):
  • [33] ASTHMA RELIEVED BY ASPIRIN AND BY OTHER CYCLO-OXYGENASE INHIBITORS
    SZCZEKLIK, A
    GRYGLEWSKI, RJ
    NIZANKOWSKA, E
    THORAX, 1978, 33 (05) : 664 - 665
  • [34] Cyclo-oxygenase (COX) inhibitors for preventing preterm labour
    Khanprakob, Thirawut
    Laopaiboon, Malinee
    Lumbiganon, Pisake
    Sangkomkamhang, Ussanee S.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (10):
  • [35] Cyclo-oxygenase II inhibitors in the treatment of neoplastic fever
    Satheesh K. Kathula
    Ketan Shah
    Hari Polenakovik
    Jhansi Koduri
    Supportive Care in Cancer, 2003, 11 : 258 - 259
  • [36] Cyclo-oxygenase 2 inhibitors: emerging roles in the gut
    Grover, JK
    Yadav, S
    Vats, V
    Joshi, YK
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2003, 18 (04) : 279 - 291
  • [37] The use of cyclo-oxygenase 2 inhibitors in South Africa
    Truter, Ilse
    SA PHARMACEUTICAL JOURNAL, 2011, 78 (04) : 14 - 17
  • [38] ANALYSIS OF CYCLO-OXYGENASE AND LIPOXYGENASE PRODUCTS IN INFLAMMATORY EXUDATE
    SALMON, JA
    PROSTAGLANDINS, 1984, 27 (03): : 364 - 366
  • [39] Synthesis, Molecular Docking, and Anti-inflammatory Activities of Some Novel Benzimidazole Derivatives as Potential Cyclo-oxygenase-2 Inhibitors
    Elrayess, Ranza
    Elrayess, Ranwa
    Ghareb, Nagat
    EGYPTIAN JOURNAL OF CHEMISTRY, 2024, 67 (01): : 255 - 266
  • [40] Cyclo-oxygenase selectivity and chemical groups of nonsteroidal anti-inflammatory drugs and the frequency of reporting hypersensitivity reactions: a case/noncase study in VigiBase
    Bakhriansyah, Mohammad
    Meyboom, Ronald H. B.
    Souverein, Patrick C.
    de Boer, Anthonius
    Klungel, Olaf H.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 (05) : 589 - 600